Neuropsychiatric Research Databases for People With Intellectual Disabilities and Epilepsy (REFINE)

NCT ID: NCT06780501

Last Updated: 2025-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-12

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study consists of two parts:

Part One: De-identified Database

The goal of this part is to establish a research database containing de-identified data about People with Intellectual Disabilities (PwID) and epilepsy, collected from three NHS sites across England and Wales. Researchers will gather information from participants' medical records, including clinical details, epilepsy history, and medications, and will enter this data into a secure database where all identifying details are removed. This part of the study aims to determine whether it's possible to identify eligible participants, collect complete datasets for each participant, and identify any issues that may affect the quantity and quality of data. These findings will help inform a potential future study that could involve 20 or more sites.

Part Two: Research Register

The goal of this part is to create a research register of individuals with PwID and epilepsy. Participants will be approached and asked for their consent to collect their personal and clinical data, which will help identify those willing to take part in future ethically approved research projects. As in Part One, researchers will collect data from medical records. Participants who consent to be included in the register may be contacted by external researchers for future studies. The aim is to facilitate national collaboration by enabling data sharing between research projects, thereby improving the ability to answer more questions and enhance patient care. This part of the study will test whether it's possible to determine screening and recruitment rates at each site, develop and evaluate recruitment processes, and assess how researchers leading other approved studies can obtain permission to use the register. Additionally, it will evaluate whether it's possible to collect a complete dataset for each participant.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy Intellectual Disability Learning Disability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of ID in medical records.
* Clinical diagnosis of epilepsy in medical records.
* Patient is over the age of 18 years old.
* Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts.


* Clinical diagnosis of ID in medical records.
* Clinical diagnosis of epilepsy in medical records.
* Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts.
* Between the ages of 18 and 30 at the time of consent.
* Participant has the capacity to be able to provide consent for themselves, or a personal consultee is able to provide an opinion on the views and feelings of the potential participant.
* Patients (or personal consultee) must be able to communicate in English (or Welsh in Welsh site).

Exclusion Criteria

* Other neurodevelopmental disorders without ID.
* Patient is recorded on the National Data Opt-out as not wishing their data to be used for research/audit.

The research register:


\- Other neurodevelopmental disorders without ID.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Plymouth

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Professor Rohit Shankar

Professor in Neuropsychiatry

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lance Watkins

Role: PRINCIPAL_INVESTIGATOR

Swansea Bay University Health Board

Sarah Lennard

Role: PRINCIPAL_INVESTIGATOR

Cornwall Partnership NHS Foundation Trust

Heather Angus-Leppan

Role: PRINCIPAL_INVESTIGATOR

Royal Free London NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cornwall Partnership NHS Foundation Trust

Bodmin, , United Kingdom

Site Status RECRUITING

Royal Free London Hospitals NHS Trust

London, , United Kingdom

Site Status NOT_YET_RECRUITING

Swansea Bay University Health Board

Swansea, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rohit Shankar

Role: CONTACT

+44 (0) 1752 439831

Emily Stanyard

Role: CONTACT

+44 (0) 1752 439831

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sarah Lennard

Role: primary

Heather Angus-Leppan

Role: primary

Lance Watkins

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5284

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.